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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major public health problem and gives arise to
severe chronic morbidity and mortality in the world. Inflammatory response and oxidative stress play dominant
roles in the pathological mechanism of COPD, and have been regarded to be two important targets for the COPD
therapy. Traditional Chinese medicines (TCMs) possess satisfying curative effects on COPD under guidance of the
TCM theory in China, and merit in-depth investigations as a resource of lead compounds.
Methods: One hundred ninety-six of TCMs were collected, and extracted to establish a TCM extract library, and
then further evaluated for their potency on inhibitions of oxidative stress and inflammatory response using
NADP(H):quinone oxidoreductase (QR) assay and nitric oxide (NO) production assay, respectively.
Results: Our investigation observed that 38 of the tested TCM extracts induced QR activity in hepa 1c1c7 murine
hepatoma cells, and 55 of them inhibited NO production in RAW 264.7 murine macrophages at the tested
concentrations. Noteworthily, 20 of TCM extracts simultaneously inhibited oxidative stress and inflammatory
responses.
Conclusion: The observed bioactive TCMs, particularly these 20 TCMs with dual inhibitory effects, might be useful
for the treatment of COPD. More importantly, the results of the present research afford us an opportunity to
discover new lead molecules as COPD therapeutic agents from these active TCMs.
Keywords: Traditional Chinese medicines, Chronic obstructive pulmonary disease, Oxidative stress, Inflammatory
response
Background
Chronic obstructive pulmonary disease (COPD) is a dis-
ease characterized by progressive and not fully reversible
airflow limitation, which is associated with abnormal
inflammatory response of the lung to noxious particles
and gases [1]. Tobacco smoke, indoor and outdoor air
pollutions, as well as exposure to occupational dust and
chemicals are the three dominant risk factors for COPD.
It is the fourth leading cause of chronic morbidity and
mortality in the United States. On the basis of investiga-
tion by the World Bank/World Health Organization,
COPD is predicted to rank fifth in 2020 as a worldwide
burden of disease. A horrifying fact is that half of global
deaths from COPD occur in the Western Pacific Region,
with the majority of these existing in China, which might
be contributing to high incidence of smoking and severe
air pollution in the industrialization advancement [2].
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Cumulative evidences indicate that inflammatory re-
sponse, oxidative stress, and protease imbalance play
dominant roles in the pathological mechanism of COPD
[3, 4]. Briefly, exogenous irritants and reactive oxygen
species (ROS) activate inflammatory cells (e.g. macro-
phages, neutrophils) and epithelial cells in the respira-
tory tract that release ROS, inflammatory mediators [e.g.
leukotriene B4 (LTB4), interleukin-8 (IL-8), tumor ne-
crosis factor α (TNFα), transforming growth factor-β
(TGF-β)], proteases (e.g. cathepsins, matrix metallopro-
teinases)[3, 5, 6]. ROS stimulates nuclear factor kB (NF-
kB) and increase the release of inflammatory cytokines,
inflammatory mediators promote the production of
endogenous ROS, while proteases cause alveolar de-
struction and mucus secretion. Hence, the synergistic re-
actions of inflammation, oxidative stress, and protease
imbalance amplify pathophysiology of COPD, and inhi-
bitions of these three processes are regarded to be effect-
ive strategies for the treatment, as well as drug research
and development of COPD [7].
Plenty of traditional Chinese medicines (TCMs)
have been used clinically to treat COPD in the form
of single or compound prescription under guidance of
the TCM theory in China, and demonstrated satisfy-
ing curative effects [8, 9]. Their clinical effectiveness
implies that TCM is an important resource of new
drugs and/or lead compounds with COPD therapeutic
potential. Based on this rationale, we have launched a
systemic research on discovering new drugs and lead
molecules for COPD treatment from TCM targeting
inhibitions of oxidative stress and inflammatory response.
We firstly collected and extracted TCM materials to
establish a TCM extract library, and then carried out a
biological screening of these TCMs using NADP(H):qui-
none oxidoreductase (QR) assay and nitric oxide (NO)
production assay to find the TCMs with potential thera-
peutic effect on COPD.
Methods
Chemicals
Sulforaphane (SF, purity >98 %) was purchased from
Sigma-Aldrich (St. Louis, MO, USA). Didox (purity >98 %)
was purchased from MedChem Express (Monmouth
Junction, ON, USA). Solvents used for extraction were of
analytical grade and obtained from Tianjin Fuyu Chemical
Company (Tianjin, China).
Collection and Identification of tested TCMs
Traditional Chinese medicine (TCM) materials were
purchased from the Jinan Jianlian TCM Co. Ltd in
Shandong province, Anguo TCM market in Hebei
province, and Bozhou TCM market in Anhui Province.
These TCMs were identified by Prof. Lan Xiang, School of
Pharmaceutical Sciences, Shandong University, through
comparing their characteristics in plant morphology and
taxonomy with that described in Chinese Pharmacopoeia.
Voucher specimens (Voucher ID see Table 1) of TCMs
have been deposited at the Laboratory of Pharmacognosy,
School of Pharmaceutical Sciences, Shandong University.
Preparations of TCM extractions
Crushed aerial parts or leaves of plant materials (50 g)
were extracted under reflux for 2 h with 75 % ethanol
(EtOH, 2 × 500 mL), and then EtOH was removed under
reduced pressure. The yield of each extract was pre-
sented as a percentage of weight of dried plant material,
and has been summarized in Table 1.
Cell cultures
Hepa 1c1c7 murine hepatoma cells (American Type Cul-
ture Collection, ATCC) were maintained in Eagle’s
minimal essential medium (MEM, Gibco) supplemented
with 10 % fetal bovine serum (FBS, Gemini Bio-product).
RAW 264.7 murine macrophages (ATCC) were cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco)
supplemented with 10 % FBS. All cells were incubated at
37 °C in a humidified incubator containing 5 % CO2.
NADP(H): quinone oxidoreductase (QR) assay
NADP(H):quinone oxidoreductase (QR) assay was modi-
fied from previously described method [10]. Hepa 1c1c7
cells (1.0 × 104 cells/well) were seeded in 96-well plates
and treated with the indicated doses of tested extracts
for 24 h. The medium was decanted, and the cells were
incubated with 40 μL of lysing solution [0.8 % digitonin
and 2 mM EDTA solution (pH 7.8)] for 15 min at 37 °C.
Then, 170 μL of a complete reaction mixture containing
bovine serum albumin, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide (MTT), 1.5 % Tween 20,
0.5 M Tris–HCl, 7.5 mM flavin adenine dinucleotide
(FAD), 150 mM glucose-6-phosphate, 10 units/μL
glucose-6-phosphate dehydrogenase, 50 mM NADP, and
50 mM menadione was added into each well. After incu-
bation for 4 min, a blue color was developed and the
reaction was arrested by adding 50 μL per well of a
0.3 mM dicoumarol solution (pH 7.4). Absorbance was
measured at 630 nm on the Model 680 plate reader
(Bio-rad). SF (2.0 μM) was adopted as a positive control.
Nitric oxide (NO) production assay
Inhibition of NO production by LPS-stimulated RAW
264.7 murine macrophages was applied to evaluate anti-
inflammatory functions of TCM extracts. RAW 264.7
cells (8.0 × 104 cells/well) were seeded in 96-well plates
and treated with 1 μg/mL LPS, in the absence or
presence of tested TCM extractions for 24 h. Then,
100 μL of supernatant was removed to a new 96-well
plate and added with 100 μL of Griess reagent (0.1 %
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Table 1 Inhibitions on oxidative stress and inflammation of TCMs evaluated using QR induction and NO production assay
No Plant name Part used
in TCM




1 Acacia catechu (L.f.) Wild. Branch 20151128-100-EC 69.8 N/D N/D
2 Acanthopanax gracilistylus W. W. Smith Root-bark 20150802-20-WJP 9.8 N/D 68.0 % (100)
3 Acanthopanax senticosus (Rupr. et Maxim.) Harms Rhizome 20150801-8-CWJ 7.7 N/D 52.0 % (200)
4 Achyranthes bidentata Bl. Rhizome 20150801-4-NX 8.7 N/D N/D
5 Aconitum carmichaeli Debx. Root 20151128-58-FZ 14.7 N/D N/D
6 Acorns tatarinowii Schott Rhizome 20151128-30-SCP 10.5 N/D N/D
7 Adenophora tetraphylla (Thunb.) Fisch. Root 20151128-76-SS 19.1 N/D N/D
8 Agrimonia pilosa Ledeb. Aerial part 20151128-31-XHC 9.8 N/D 41.2 % (200)
9 Akebia trifoliata (Thunb.) Koidz. subsp.
australis (Diels) T. Shimizu
Rattan 20150802-14-BMT 11.6 N/D N/D
10 Albizia julibrissin Durazz. Bark 20151128-134-HHP 8.9 1.64 fold (200) N/D
11 Alisma orientalis (Sam.) Juzep. Root 20151128-71-ZX 13.6 N/D 34.2 % (200)
12 Allium tuberosum Rottl. Seed 20150717-4-JCZ 3.8 N/D N/D
13 Amomum kravanh Pierre ex Gagnep. Fruit 20151128-137-DK 2.1 N/D N/D
14 Amomum villosum Lour. Fruit 20150801-9-SR 8.3 N/D N/D
15 Ampelopsis japonica (Thunb.) Makino Root 20151128-127-BL 10.7 N/D N/D
16 Andrographis paniculata (Burm.f.) Nees Aerial part 20151128-83-CXL 9.9 2.04 fold (200) N/D
17 Anemarrhena asphodeloides Bge. Rhizome 20150802-17-ZM 10.2 N/D 41.2 % (200)
18 Angelica dahurica (Fisch. ex Hoffm.) Benth. et Hook.f. Root 20151128-125-BZ 8.9 N/D N/D
19 Angelica pubescens Maxim. f. biserrata Shan et Yuan Root 20150802-16-DH 25.1 N/D N/D
20 Angelica sinensis (Oliv.) Diels Root 20151128-34-DG 19.4 1.41 fold (200) N/D
21 Arctium lappa L. Fruit 20151128-33-NBZ 18.4 N/D N/D
22 Areca catechu L. Peel 20151128-104-DFP 2.3 N/D N/D
23 Areca catechu L. Fruit 20151128-145-BL 8.2 1.33 fold (25) N/D
24 Arisaema erubescens (Wall.) Schott Tuber 20151128-23-TNX 1.2 1.36 fold (200) N/D
25 Aristolochia debilis Sieb. et Zucc. Aerial part 20151128-21-TXT 3.2 N/D N/D
26 Artemisia argyi Levi. et Vant. Leaf 20150716-6-AY 12.9 N/D 86.2 % (200)
27 Artemisia scoparia Waldst. et Kit. Aerial part 20151128-74-YC 12.8 1.48 fold (200) 38.8 % (100)
28 Asarum heterotropoides Fr. Schmldt var.
mandshuricum (Maxim.) Kitag.
Root and rhizome 20151128-72-XX 11.4 N/D N/D
29 Atractylode lancea (Thunb.) DC. Rhizome 20151128-136-CZ 24.2 N/D 52.3 %(200)
30 Atractylodes macrocephala Koldz. Rhizome 20151128-123-BZ 12.9 N/D N/D
31 Aucklandia lappa Decne. Root 20151128-15-MX 16.3 2.31 fold (25) 94.7 % (25)
32 Belamcanda chinensis (L.) DC. Rhizome 20151128-106-SG 29.6 N/D N/D
33 Bletilla striata (Thunb.) Reichb.f. Rhizome 20150801-12-BJ 2.1 N/D N/D
34 Bolbostemma paniculatum (Maxim.) Franquet Tuber 20151128-5-TBM 15.1 N/D N/D
35 Callicarpa macrophylla Vahl Leaf 20151128-7-DYZZ 4.3 N/D 85.8 % (200)
36 Cassia angustifolia Vahl. Leaf 20150802-25-FXY 9.4 1.54 fold (50) 79.7 % (200)
37 Cassia obtusifolia L. Seed 20151128-38-JMZ 7.9 N/D N/D
38 Chaenomeles speciosa (Sweet) Nakai Fruit 20151128-24-MG 30.5 N/D N/D
39 Chrysanthemum morifolium Ramat. Flower 20150802-28-JH 23.3 N/D 90.2 % (200)
40 Cimicifuga heracleifolia Kom. Rhizome 20151128-28-SM 14.1 1.95 fold (100) 86.4 % (200)
41 Cinnamomum cassia Presl Branch 20150717-2-GZ 5.0 N/D N/D
42 Cirsium japonicum Fisch. ex DC. Aerial part 20151128-9-DJ 6.7 N/D N/D
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43 Cirsium setosum (Willd.) M.Bieb. Aerial part 20151128-10-XJ 12.7 1.51 fold (200) 38.8 % (200)
44 Cistanchede deserticola Y. C. Ma Stem 20150801-7-RCR 23.6 N/D N/D
45 Citrus aurantium L. Fruit 20150801-11-ZQ 17.0 N/D N/D
46 Citrus limon (L.) Burm. f. Fruit 20150716-16-NM 19.5 1.79 fold (200) N/D
47 Citrus medica L. var. sarcodac-tylis Swingle Fruit 20151128-55-FS 39.6 N/D N/D
48 Citrus reticulata Blanco. Pericarp 20150716-10-CP 22.0 N/D N/D
49 Clematis armandii Franch. Rattan 20150802-12-CMT 4.5 N/D N/D
50 Codonopsis pilosula(Franch.) Nannf. Root 20151128-59-DS 48.4 N/D N/D
51 Coix lacryma-jobi L. var. ma-yuen (Roman.) Stapf Seed 20150716-15-YYR 6.5 N/D N/D
52 Commelina communis L. Aerial part 20151128-88-YZC 4.4 N/D N/D
53 Coptis chinensis Franch. Rhizome 20150802-31-HL 6.6 N/D 57.1 %(200)
54 Cornus officinalis Sieb. et Zucc. Fruit 20150802-27-SZY 43.6 N/D N/D
55 Crataegus pinnatifida Bge. var. major N. E. Br. Fruit 20150716-2-SZ 34.8 N/D N/D
56 Cremastra appendiculata (D. Don) Makino Pseudobulb 20151128-12-SCG 2.6 N/D 61.0 % (200)
57 Croton tiglium L. Fruit 20150802-8-BD 1.1 N/D N/D
58 Curculigo orchioides Gaertn. Rhizome 20151128-121-XM 4.5 1.57 fold (200) 47.8 % at (200)
59 Curcuma phaeocaulis Val. Rhizome 20150801-20-EZ 2.6 N/D 66.9 % (25)
60 Curcuma wenyujin Y. H. Chen et C. Ling Root 20150802-26-YJ 9.0 N/D N/D
61 Cynanchum atratum Bge. Root and rhizome 20151128-40-BW 23.6 N/D N/D
62 Cynanchum stauntonii (Decne.) Schltr ex Lévl. Rhizome 20150801-13-BQ 10.6. N/D N/D
63 Cynomorium songaricum Rupr. Stem 20150716-14-SY 17.9 N/D N/D
64 Cyperus rotundus L. Rhizome 20151128-80-XF 11.6 1.74 fold (200) N/D
65 Dendrobium nobile Lindl. Stem 20150802-13-MH 9.0 N/D 38.9 % (200)
66 Dictamnus dasycarpus Turcz. Velamen 20150802-4-BXP 9.0 N/D N/D
67 Dioscorea opposita Thunb. Rhizome 20150716-1-SY 1.7 N/D N/D
68 Dipsacus asperoides C. Y. Cheng et T. M. Ai Rhizome 20150716-13-XD 17.5 N/D 38.6 % (200)
69 Drynaria fortunei (Kunze) J. Sm. Rhizome 20151128-78-GSB 4.8 N/D N/D
70 Eclipta prostrata L. Aerial part 20151128-99-MHL 9.0 N/D N/D
71 Epimedium brevicornum Maxim. Aerial part 20150716-9-YYH 20.5 N/D N/D
72 Equisetum hiemale L. Aerial part 20151128-108-MZ 4.9 N/D 41.7 %(200)
73 Eriocaulon buergerianum Koern. Flower 20151128-139-GJC 7.9 N/D N/D
74 Eucommia ulmoides Oliv. Root-bark 20151128-51-DZ 8.3 1.56 fold (200) 62.5 % (200)
75 Eugenia caryophyllata Thunb. Bud 20151128-1-DX 27.5 N/D N/D
76 Eupatorium fortunei Turcz. Aerial part 20151128-66-PL 10.1 N/D N/D
77 Euphorbia humifusa Willd. Whole plant 20151128-37-DJC 9.5 N/D N/D
78 Ferula Sinkiangensis K. M. Shen Resin 20151128-140-EW 6.1 N/D N/D
79 Forsythia suspense (Thnub.) Vahl Fruit 20151128-53-LQ 28.3 N/D 48.3 % (200)
80 Fraxinus rhynchophylla Hance Bark 20151128-86-QP 8.0 N/D 90.7 % (200)
81 Fritillaria ussuriensis Maxim. Bulb 20151128-118-PBM 4.1 N/D N/D
82 Ganoderma sinense Zhao, Xu et Zhang Sporophore 20150801-2-ZZ 2.9 N/D N/D
83 Gardenia jasminoides Ellis. Fruit 20150717-7-ZZ 16.1 N/D N/D
84 Gastrodia elata Bl. Tuber 20150801-16-TM 7.5 N/D N/D
85 Glycyrrhiza uralensis Fisch. Rhizome 20150716-5-GC 15.7 2.19 fold (100) 82.9 % (200)
86 Hippophae rhamnoides L. Fruit 20151128-57-SJ 36.5 N/D N/D
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87 Homalomena occulta (Lour.) Schott Rhizome 20151128-13-QNJ 9.3 N/D N/D
88 Hordeum vulgare L. Fruit 20151128-135-MY 11.5 N/D N/D
89 Houttuynia cordata Thunb. Aerial part 20150801-18-YXC 16.7 N/D N/D
90 Illicium difengpi K. I .B. et K. I. M. Bark 20151128-132-DFP 1.9 1.52 fold (100) N/D
91 Illicium verum Hook. f. Fruit 20151128-2-BJHX 13.3 N/D 55.7 % (200)
92 Inula helenium L. Root 20150802-5-TMX 13.2 1.77 fold (12.5) 100 % (100)
93 Isatis indigotica Fort. Root 20150802-9-BLG 17.9 N/D N/D
94 Isatis indigotica Fort. Leaf 20151128-102-DQY 13.6 1.66 fold (50) N/D
95 Kaempferia galanga L. Rhizome 20151128-105-SN 4.7 N/D N/D
96 Kochia scoparia (L.) Schrad. Fruit 20150802-23-DFZ 8.5 N/D N/D
97 Laminaria Japonica Aresch. Thallus 20150802-10-KB 18.5 N/D N/D
98 Lepidium apetalum Willd. Seed 20150802-22-TLZ 2.9 N/D N/D
99 Ligusticum chuanxiong Hort. Rhizome 20151128-19-CX 16.1 1.73 fold (200) 69.0 % (100)
100 Ligustrum lucidum Ait. Fruit 20151128-18-NZZ 24.2 N/D N/D
101 Lilium lancifolium Thunb. Leaf 20151128-32-BH 4.3 N/D N/D
102 Lindera aggregata (Sims) Kosterm. Root 20150801-15-WY 10.7 1.59 fold (200) N/D
103 Lithospermum erythrorhizon Sieb. et Zucc. Root 20151128-93-ZC 6.4 1.52 fold (50) 57.1 % (200)
104 Lobelia chinensi Lour. Whole plant 20151128-129-BBL 23.7 N/D N/D
105 Lonicera hypoglauca Miq. Flower 20150801-1-SYH 31.4 N/D N/D
106 Lonicera japonica Thunb. Flower 20150801-3-JYH 26.7 N/D N/D
107 Lophatherum gracile Brongn. Stem and leaf 20151128-91-DZY 8.6 N/D N/D
108 Lycium barbarum L. Fruit 20150801-6-GQ 11.5 N/D N/D
109 Lycium chinense Mill. Root-bark 20150802-21-DGP 7.5 N/D N/D
110 Lycopodium japonicum Thunb. Whole plant 20151128-138-SJC 22.3 N/D 53.0 % (200)
111 Lycopus lucidusTurcz. var. hirtus Regel Aerial part 20151128-70-ZL 13.5 N/D 61.6 % (200)
112 Lysimachia christinae Hance Whole plant 20151128-67-JQC 11.2 N/D N/D
113 Mahonia bealei (Fort.) Carr. Stem 20151128-114-GLM 6.1 N/D N/D
114 Melia toosendan Sleb. et Zucc. Fruit 20151128-107-CLZ 16.2 N/D N/D
115 Menispermum dauricum DC. Rhizome 20151128-120-BDG 11.0 N/D N/D
116 Mentha haplocalyx Briq. Aerial part 20150716-8-BH 19.1 N/D N/D
117 Mignolia officinalis Rehd. et Wils. Bark 20151128-84-HP 22.9 N/D N/D
118 Misla chinensis Maxim. Aerial part 20151128-81-XR 6.9 1.60 fold (100) N/D
119 Morinda officinalis How. Root 20151128-112-BJT 28.8 N/D N/D
120 Morus alba L. Branch 20151128-142-SZ 7.4 1.37 fold (100) 61.2 % (200)
121 Morus alba L. Fruit 20151128-143-SS 29.9 N/D N/D
122 Nardostachys chinensis Batal. Root and rhizome 20151128-115-GS 12.3 N/D N/D
123 Oroxylum inddicum (L.) Vent. Seed 20151128-26-MHD 14.0 N/D 85.4 % (200)
124 Orostachys fimbriatus (Turcz.) Berg. Aerial part 20151128-109-WS 6.3 N/D N/D
125 Paeonia lactiflora Pall. Rhizome 20150716-7-BS 6.4 N/D N/D
126 Panax ginseng C. A. Mey Rhizome 20150801-10-SSS 39.4 N/D N/D
127 Panax quinque folium L. Root 20150802-29-XYS 14.8 N/D N/D
128 Perilla frutescens (L.) Britt. Leaf 20150717-6-ZS 2.8 1.73 fold (200) 57.8 % (200)
129 Peucedanum praeruptorum Dunn Root 20151128-85-QH 20.6 N/D 77.6 % (200)
130 Phellodendron chinense Schneid. Tree-bark 20151128-41-HB 12.7 N/D N/D
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131 Phragmites communis Trin. Root 20151128-49-LG 3.8 N/D N/D
132 Physalis alkekengi L. var. franchetii (Mast.) Makino Calyx 20150730-2-GJD 14.2 1.79 fold (200) 91.4 % (200)
133 Pinellia ternate (Thunb.) Breit. Tuber 20151128-130-BX 0.8 1.74 fold (200) N/D
134 Piper nigrum L. Fruit 20151128-92-HHJ 5.4 N/D N/D
135 Plantago asiatica L. Whole plant 20150716-4-CQC 13.7 N/D N/D
136 Platycodon grandiflorum (Jacq.) A. DC. Root 20151128-87-JG 33.4 N/D N/D
137 Pogostemon cablin (Blanco) Benth. Aerial part 20151128-16-GHX 5.5 1.73 fold (100) 56.6 % (200)
138 Polygonatum kingianum Coll. et Hemsl. Rhizome 20151128-90-HJ 6.8 N/D N/D
139 Polygonatum odoratum (Mill.) Druce Rhizome 20151128-113-YZ 21.6 N/D N/D
140 Polygonum aviculare L. Aerial part 20151128-89-BX 10.8 N/D N/D
141 Polygonum cuspidatum Sieb. et Zucc. Root and rhizome 20151128-63-HZ 21.7 N/D 60.5 % (200)
142 Polygonum multiflorum Thunb. Root 20151128-54-HSW 6.8 N/D 35.5 % (200)
143 Polyyala tenuifolia Willd. Root 20151128-46-YZ 34.4 N/D N/D
144 Potentilla chinensis Ser. Whole plant 20151128-65-WLC 8.9 N/D N/D
145 Prunella vulgaris L. Peel 20150716-11-XKC 4.1 N/D N/D
146 Prunus armeniaca L. var. ansu Maxim. Seed 20151128-60-KXR 5.7 N/D N/D
147 Prunus persica (L.) Batsch Seed 20151128-61-TR 3.7 N/D N/D
148 Pseudolarx kaempleri Gord. Velamen 20151128-6-TJP 14.8 N/D N/D
149 Pseudostellaria beterphylla (Miq.) Pax ex Pax et Hoffm. Root 20151128-27-TZS 13.5 N/D N/D
150 Psoralea corylifolia L. Fruit 20150801-19-BGZ 10.2 N/D N/D
151 Pulsatilla chinensis (Bunge) Regel Root 20151128-124-BTW 22.7 N/D N/D
152 Punica granatum L. Peel 20151128-117-SLP 31.3 N/D N/D
153 Pyrrosia sheareri (Bak.) Ching Leaf 20151128-116-SW 12.2 1.85 fold (50) N/D
154 Rabdosia rubescens (Hemsl.) Hara Aerial part 20151128-39-DLC 8.4 1.38 fold (100) 43.2 % (200)
155 Raphanus sativus L. Seed 20150802-30-LFZ 13.8 N/D N/D
156 Rhaponlicum uniflorum (L.) DC. Root 20151128-97-LL 4.4 1.54 fold (200) N/D
157 Rheum palmatum L. Root and rhizome 20151128-103-DH 25.6 N/D 60.2 % (200)
158 Rhodiola crenulata (Hook. f. et Thoms.) H. Ohba Rhizome 20150801-5-HJT 13.3 N/D 46.3 % (200)
159 Rosa chinensis Jacq. Flower 20151128-110-YJH 18.9 N/D N/D
160 Rosa laevigata Michx. Fruit 20151128-68-JYZ 25.2 1.67 fold (50) 57 % (200)
161 Rubia cordifolia L. Root and rhizome 20151128-73-QC 10.0 N/D N/D
162 Salvia miltiorrhiza Bge. Root and rhizome 20151128-29-DS 39.7 1.44 fold (100) 64.5 % (200)
163 Sanguisorba officinalis L. Root 20151128-36-DY 3.5 N/D N/D
164 Saposhnikovia divaricata (Turcz.) Schischk. Root 20150802-19-FF 15.9 1.95 fold (100) N/D
165 Sareassum pallidum (Turn.) C. Ag. Frond 20150802-1-HZ 11.5 N/D N/D
166 Sargentodoxa cuneate (Oliv.) Rehd. et Wils. Rattan 20151128-8-DXT 16.9 N/D N/D
167 Scrophularia ningpoensis Hemsl. Root 20151128-128-XS 50.5 N/D N/D
168 Scutellaria baicalensis Georgi. Rhizome 20150716-12-HQ 30.2 N/D 87.4 %(200)
169 Scutellaria barbata D. Don Whole plant 20151128-35-BZL 10.2 N/D 59.0 % (200)
170 Sedum sarmentosum Bunge. Whole plant 20151128-64-CPC 17.5 N/D N/D
171 Selaginella tamariscina (Beauv.) Spring Whole plant 20151128-69-JB 8.9 N/D N/D
172 Senecio scandens Buch.-Ham. Aerial part 20151128-14-QLG 11.4 N/D 38.1 % (200)
173 Sesamum indicum L. Seed 20150717-3-HZM 3.3 N/D N/D
174 Siegesbeckia orientalis L. Aerial part 20151128-98-XXC 4.8 1.91 fold (200) 54.9 % (200)
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naphthylethylenediamine and 1 % sulfanilamide in 5 %
H3PO4 solution) at room temperature for 15 min. Absorb-
ance was measured at 570 nm on the Model 680 plate
reader (Bio-rad). Nitrite concentration was calculated
from a NaNO2 standard curve. Didox (100 μM) was used
as a positive control.
Cell viability assay
The anti-proliferative effect of TCM extracts on RAW
264.7 cells were simultaneously determined using a 3-
(4,5-dimthylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide (MTT, Sigma) assay. Briefly, 100 μL of DMEM media
containing 0.4 % MTT were added to each wells, after
removing 100 μL of supernatant as described in NO pro-
duction assay. Then, the cells were incubated at 37 °C
for 3 h, and absorbance was measured at 570 nm on the
Model 680 plate reader (Bio-rad).
Statistical analysis
One way analysis of variance (ANOVA) and post hoc
multiple comparison Bonferroni test were applied to
compare the significant difference between two groups.
Results are presented as the mean ± SD. P < 0.05 was
considered to be significant.
Results and Discussion
To establish a TCM extract library for biological screen-
ing, we firstly selected 196 TCMs based on Chinese
Pharmacopoeia (Edition 2015) and TCM literatures, and
collected TCMs from Jinan local TCM drugstore, as well
as the two biggest Chinese TCM markets, Anguo and
Bozhou TCM markets. After plant material authentica-
tion, TCMs were extracted with 75 % EtOH to prepare
their EtOH extracts, and then the concentrations of
200, 100, 50, 25, 12.5, 6.25 μg/mL were selected as
tested doses for bioassays. Names, origin, extract yields
and biological activities of investigated TCMs were
summarized in Table 1.
We adopted a bioassay measuring QR activity in hepa
1c1c7 murine hepatoma cells to evaluate the ability of
TCM extracts on inhibiting of oxidative stress [10].
Although QR is a phase II detoxification enzyme, it pos-
sesses same regulating mechanism with antioxidant
enzymes [e.g. glutamate-cysteine ligase, modifier subunit
(GCLM) and heme oxygenase-1 (HO-1)], since these
Table 1 Inhibitions on oxidative stress and inflammation of TCMs evaluated using QR induction and NO production assay
(Continued)
175 Siphonostegia chinensis Benth. Whole plant 20151128-119-BLJM 9.7 N/D 34.6 % (200)
176 Smilax glabra Roxb. Rhizome 20151128-101-TFL 10.9 N/D N/D
177 Sophora flavescens Ait. Root 20151128-62-KS 21.4 N/D N/D
178 Sophora japonica L. Flower and bud 20151128-95-HH 37.1 1.44 fold (200) N/D
179 Sparganium stoloniferum Buch.-Ham. Tuber 20151128-3-SL 4.5 1.57 fold (200) N/D
180 Spatholobus suberectus Dunn Rattan 20151128-56-JXT 5.8 N/D N/D
181 Stemona sessilifolia (Miq.) Miq. Root 20150802-24-BB 30.6 N/D N/D
182 Stephania tetrandra S. Moore Root 20151128-43-FJ 72.9 N/D 50.0 % (200)
183 Sterculia lychnophora Hance Seed 20150801-21-PDH 3.2 N/D 30.7 % (200)
184 Taraxacum mongolicum Hand.-Mazz. Whole plant 20150716-3-PGY 17.2 N/D 42.3 % (200)
185 Taxillus chinensis (DC.) Danser Aerial part 20150802-15-SJS 6.3 N/D N/D
186 Trichosanthes kirilowii Maxim. Seed 20131120-1-GL 20.5 N/D N/D
187 Tripterygium wilfordii Hook. f. Root 20150802-18-LGT 8.3 N/D N/D
188 Tussilago farfara L. Bud 20150802-6-KDH 9.9 2.38 fold (50) N/D
189 Uncaria rhynchophylla (Miq.) Miq. ex Havil. Stem 20151128-79-GT 6.5 N/D N/D
190 Usnea diffracta Vain. Thallus 20150802-2-SL 11.0 N/D 44.5 % (200)
191 Vaccaria segetatis (Neck.) Garcke Seed 20151128-20-WBLX 4.9 N/D N/D
192 Verbena officinalis L. Aerial part 20151128-17-MBC 7.9 N/D N/D
193 Viola yedoensis Makino Whole plant 20150802-7-ZHDD 25.6 N/D N/D
194 Xanthium sibiricum Patr. Fruit 20151128-47-CEZ 3.5 N/D N/D
195 Zanthoxylum nitidum (Roxb.) DC. Root 20151128-52-LMZ 6.1 N/D 38.2 % (200)
196 Zanthoxylum schinifoliumSleb. et Zucc. Peel 20151128-48-HJ 21.2 1.75 fold (200) 50.3 % (200)
SF (2.0 μM) with an approximately 1.7-fold induction was used as a positive control for QR assay; Didox (100 μM) with an approximately 60 % inhibition of NO
production was adopted as a positive control for NO inhibitory assay; MQI: the maximum folds of QR inducing activity under the tested concentration; MIR: the
maximum inhibition rate of NO production under the nontoxic tested concentration; N/D, undetected
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enzymes are antioxidant response element (ARE)-con-
taining target genes and are mediated by ARE located in
their promoter region [11]. Specially, upon the exposure
of cells to oxidative stress and/or toxicants, nuclear fac-
tor E2-related factor 2 (Nrf2) translocates into the nu-
cleus, binds to the ARE sequence, and activates the
transcription of these ARE-target genes [12]. Therefore,
QR and antioxidant enzymes (e.g. GCLM and HO-1)
possess same responses against endogenous and exogen-
ous insults, which have also been verified by our recent
researches [13, 14]. Considering above mentioned indu-
cing mechanism of QR and antioxidant enzymes, deter-
mination of QR activity is a rational and effective
method for analyzing the potency of oxidative stress in-
hibition. In the current study, we normalized the data by
setting the untreated control group as 1, and then the
QR inducing activity of tested extracts was represented
by the maximum folds of QR inducing activity (MQI)
compared with the untreated control group. SF as a posi-
tive control displayed an approximately 1.7-fold induction
at 2.0 μM. 1.3-fold of QR inducing activity (MQI = 1.3)
under the tested concentrations was adopted as a criterion
for bioactive TCM extracts. To be more precise, the level
of QR inducing activity was ranked as the following
criteria: strong (MQI ≥ 1.8); moderate (1.8 >MQI ≥1.5);
weak (1.5 >MQI ≥1.3); undetected (MQI < 1.3).
Ultimately, 38 TCM extracts demonstrated the QR
inducing activities with MQI ranging from 1.33- to
2.38- folds under the tested concentrations (Table 1).
Of which, eight TCM extracts strongly induced QR
activity in hepa 1c1c7 cells (MQI ≥ 1.8), including
Andrographis paniculata (aerial part, 16), Aucklandia
lappa (root, 31), Cimicifuga heracleifolia (rhizome, 40),
Glycyrrhiz uralensis (rhizome, 85), Pyrrosia sheareri
(leaf, 153), Saposhnikovia divaricate (root, 164), Sieges-
beckia orientalis (aerial part, 174), and Tussilago farfara
(bud, 188). Twenty-two extracts are moderate QR
inducers (1.8 > MQI ≥1.5), containing Albizia julibrissin
(bark, 10), Cassia angustifolia (leaf, 36), Cirsium setosum
(aerial part, 43), Citrus limon (fruit, 46), Curculigo
orchioides (rhizome, 58), Cyperus rotundus (rhizome, 64),
Eucommia ulmoides (root-bark, 74), Illicium difengpi
(bark, 90), Inula helenium (root, 92), Isatis indigotica (leaf,
93), Ligusticum chuanxiong (rhizome, 99), Lindera aggre-
gate (root, 102), Lithospermum erythrorhizon (root, 103),
Misla chinensis (aerial part, 118), Perilla frutescens (leaf,
128), Physalis alkekengi L. var. franchetii (calyx, 132),
Pinellia ternata (tuber, 133), Pogostemon cablin (aerial
part, 137), Rhaponlicum uniflorum (root, 156), Rosa laevi-
gata (fruit, 160), Sparganium stoloniferum (tuber, 179),
and Zanthoxylum schinifolium (peel, 196). Moreover, eight
extracts possessed weak QR inducing effect (1.5 >MQI
≥1.3), including Angelica sinensis (root, 20), Areca catechu
(fruit, 23), Arisaema erubescens (tuber, 24), Artemisia
scoparia (aerial part, 27), Morus alba (branch, 120),
Rabdosia rubescens (aerial part, 154), Salvia miltiorrhiza
(root and rhizome, 162), and Sophora japonica (flower
and bud, 178). QR inducing effects of 38 bioactive TCM
extracts in hepa 1c1c7 cells have been detailedly summa-
rized in Additional file 1: Table S1 and Figure S1.
During the chronic inflammation process, excessive
NO have been produced and involved in the tissue
injury through damages to proteins, lipids, DNA, and
the modulation of leukocyte activity [15]. Accordingly,
inhibiting NO production is regarded to be an effective
strategy for the therapy of inflammation-related dis-
eases. Herein, we detected NO level in LPS-stimulated
RAW264.7 macrophages to evaluate anti-inflammatory
function of TCM extracts. Cytotoxicities of tested TCM
extracts were simultaneously evaluated by a MTT assay
to confirm that the decrease of NO production was not
attributed to inhibition of cell proliferation. The max-
imum inhibition rate (MIR) of NO production under
the nontoxic tested concentration, which was calculated
by comparing the decreased NO concentration in
TCM-treated group with that in LPS-stimulated group,
was adopted to evaluate the anti-inflammatory property.
Didox with an approximately 60 % inhibition of NO pro-
duction at 100 μM was used as a positive control. The
inhibitory potency of TCM extracts on NO production
was ranked according to the criteria as follows: strong
(MIR ≥ 80 %); moderate (80 % >MIR ≥ 50 %); weak
(50 % >MIR ≥ 30 %); undetected (MIR <30 %).
Our investigation indicated that 55 TCM extracts inhib-
ited the LPS-induced NO production with MIRs between
30.7 % and 100 % under the tested nontoxic concentra-
tions (Table 1). Thereinto, 11 TCM extracts strongly
inhibited NO production in RAW 264.7 cells (MIR ≥
80 %), including Artemisia argyi (leaf, 26), Aucklandia
lappa (root, 31), Callicarpa macrophylla (leaf, 35),
Chrysanthemum morifolium (flower, 39), Cimicifuga hera-
cleifolia (rhizome, 40), Fraxinus rhynchophylla (bark, 80),
Glycyrrhiza uralensis (rhizome, 85), Inula helenium (root,
92), Oraxylum inddicum (seed, 123), Physalis alkekengi L.
var. franchetii (calyx, 132), and Scutellaria baicalensis (rhi-
zome, 168). Moreever, 25 extracts displayed moderate in-
hibitory effect of NO production (80 % >MIR ≥ 50 %), and
19 extracts weakly inhibited NO production (50 % >MIR
≥30 %). Inhibitory effects on NO production of 55 bio-
active TCM extracts in RAW 264.7 cells have been
detailedly summarized in Additional file 1: Table S1 and
Figure S1.
Since oxidative stress and inflammatory response have
the synergistic reactions in the pathophysiology of
COPD, TCMs having dual inhibitions on the two targets
are apt to be the resource for discovering lead molecules
[5, 7]. Our results indicated that the extracts of
Artemisia scoparia (aerial part, 27), Aucklandia lappa
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(root, 31), Cassia angustifolia (leaf, 36), Cimicifuga
heracleifolia (rhizome, 40), Cirsium setosum (aerial part,
43), Curculigo orchioides (rhizome, 58), Eucommia
ulmoides (root-bark, 74), Glycyrrhiza uralensis (rhizome,
85), Inula helenium (root, 92), Ligusticum chuanxiong
(rhizome, 99), Lithospermum erythrorhizon (root, 103),
Morus alba (branch, 120), Perilla frutescens (leaf, 128),
Physalis alkekengi var. franchetii (calyx, 132), Pogoste-
mon cablin (aerial part, 137), Rabdosia rubescens (aerial
part, 154), Rosa laevigata (fruit, 160), Salvia miltiorrhiza
(root and rhizome, 162), Siegesbeckia orientalis (aerial
part, 174), and Zanthoxylum schinifolium (peel, 196)
simultaneously inhibited oxidative stress and inflamma-
tion (Table 1 and Additional file 1: Table S1). Most of
all, both QR inducing effects and NO inhibitory activ-
ities of the extracts of Aucklandia lappa (31), Cimicifuga
heracleifolia (40), and Glycyrrhiza uralensis (85) are la-
belled as the level of strong. In addition, the extracts of
Inula helenium (92) and Physalis alkekengi L. var. fran-
chetii (132) also demonstrated the potencies that are
closed to the strong level.
To our knowledge, this is the first systemic screening
of QR inducing extracts from TCMs to discover TCMs
with the capacity of inhibiting oxidative stress. Plenty of
work on investigation of natural-derived molecules for
their regulation on oxidative stress have been carried
out, and acquired some active ingredients existed in
above evaluated TCMs, such as andrographolide from
Andrographis paniculata (16) [16], (Z)-ligustilide from
Angelica sinensis (20) [17], dehydroglyasperin C from
Glycyrrhiza uralensis (85) [18], isoalantolactone from
Inula helenium (92) [19], 2’,3’-dihydroxy-4’,6’-dimethoxy-
chalcone from Perilla frutescens (128) [20], oridonin
from Rabdosia rubescens (154) [21], danshensu and tan-
shinone I from Salvia miltiorrhiza (162) [22]. These data
support our observed QR inducing effects of the active
TCMs. More importantly, the majority of QR inducing
TCMs tested in present research have still not been phy-
tochemically investigated through targeting oxidative
stress inhibition, which affords us an opportunity to dis-
cover new lead molecules from them [23].
TCMs have been adopted for the therapy of
inflammation-related diseases with a long history in China.
Compared with QR inducing assay, NO inhibitory effect
assay and other in vitro and in vivo anti-inflammatory
models are classical and commonly adopted biological
research methods, and accordingly more literatures con-
cerning inflammation of TCMs have been published. Based
on our findings, we carried out a systemic search of
reported inflammation-related literatures of our observed
55 active TCM extracts, and concluded that: some TCMs
have been comprehensively investigated for their anti-
inflammatory property and resulted in the discovery of di-
verse types of natural products, covering agrimonolide from
Agrimonia pilosa (8) [24], (-)-nyasol from Anemarrhena
asphodeloides (17) [25], alantolactone from Aucklandia
lappa (31) [26], berberine from Coptis chinensis (53) [27],
forsythiaside from Forsythia suspensa (79) [28], resveratrol
from Polygonum cuspidatum (141) [29], etc. Beside
these comprehensively investigated molecules, a great
deal of constituents have been isolated from these
active TCMs, and required further confirmation of
their anti-inflammatory function. Meanwhile, a num-
ber of TCMs [e.g. Alisma orientalis (11), Equisetum
hiemale (72), Cirsium setosum (43)] have not been in-
vestigated in the field of inflammation. Significantly,
little research on the therapeutic effect of COPD has
been performed, and thus these active TCMs are still
being researched.
In the present screening assay, we only adopted two
typical markers, QR and NO, to evaluate the potential of
TCMs as oxidative stress and inflammation inhibitory
agents. Based on our preliminary results, active TCM
extracts could be subjected to further research in the
field of phytochemistry and pharmacology, however,
solid evidences on their biological functions are required
before a systemic investigation [14]. With regard to the
inhibition on oxidative stress, the levels of endogenous
glutathione (GSH) and reactive ROS, as well as the pro-
tein level of key intracellular redox-balancing protein
GCLM, are suggested to be detected to estimate the
intracellular redox state and antioxidant capacity when
exposed to TCM extracts [30–32]. Concerning the inhib-
ition of inflammation by the active TCMs, the levels of
crucial inflammatory mediators in the COPD pathology,
including TNFα, LTB4, and IL-8, should be determined to
confirm their anti-inflammatory potential [33].
Additionally, the pivotal regulators for oxidative
stress and inflammation should be sufficiently investi-
gated to verify action of mechanism of the active
TCMs. The transcription factor Nrf2 plays a dominant
role for regulating oxidative stress. It is ubiquitously
expressed in human organs, particularly rich in lung,
and counteracts oxidative injury through activating
intracellular redox-balancing proteins (e.g. GCLM,
GST, HO-1) and up-regulating endogenous antioxi-
dants (e.g. GSH) [11, 34]. NF-kB regulates the expres-
sion of proinflammatory genes including cytokines,
chemokines, and adhesion molecules, and its inhibition
therefore definitely relieves the inflammatory response
of COPD [7, 35]. It has also been verified that phos-
phatidylinositol 3-kinase (PI3K) and mitogen-activated
protein kinase (MAPK) are involved in the regulation
of inflammatory response [36, 37]. Hence, the further
research on active TCM extracts and purified ingredi-
ents could focus on their action of mechanism on Nrf2,
NF-kB, PI3K, and MAPK signaling pathways, as well as
the cross talk between these pathways.
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Conclusion
Although the present research indicates that some
TCMs possessed inhibitory effects on inflammation and
oxidative stress, further pharmacological investigations
in vitro and in vivo models are warranted. Furthermore,
bioassay-guided fractionations and identifications of
active ingredients should be launched to help us illus-
trate the mechanism of these active species, and discover
new lead molecules with unknown mechanisms and
potent functions on oxidative stress- and inflammation-
related diseases, especially COPD. Accordingly, these
results may give new insight in research and develop-
ment of COPD therapeutic agents.
Additional file
Additional file 1: Figure S1. NADP(H): quinone oxidoreductase (QR)
inducing effects of 38 bioactive TCM extracts in hepa 1c1c7 cells. The QR
inducing effect was determined after 24h treatment of the hepa 1c1c7
cells in the presence or absence of tested TCMs. The data of the
untreated control group was normalized as 1, and then the QR inducing
activity of tested extracts was represented by the maximum folds of QR
inducing activity (MQI) compared with the untreated control group.
Sulforaphane (SF, 2.0 μM) was used as a positive control. The data are
reported the means ± SD from three independent experiments. Figure
S2. Inhibitory effects on NO production of 55 bioactive TCM extracts in
RAW 264.7 cells. The NO concentration in the RAW 264.7 cell culture
media was determined through the Griess reaction 24 h after treated in
the presence or absence of tested TCMs and lipopolysaccharides (LPS, 1.0
μg/mL). Didox (100 μM) was adopted as a positive control. The data are
reported the means ± SD from three independent experiments. The
maximum inhibition rates (MIRs) of NO production under the untoxic
tested concentration were calculated by comparing the decreased NO
concentration in TCM-treated group with that in LPS-stimulated group.
Table S1. TCM extracts with QR inducing activity and/or NO inhibitory
effect. (DOCX 4312 kb)
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